BioSpace News Archive

Business

Biogen Issues Work-from-Home Order Following More Positive COVID-19 Tests

According to reports, 15 employees who attended a management meeting in Boston have now tested positive for the virus.

March 9, 2020
·
3 min read
·
Alex Keown
Business

OncoNano: New Approaches to Old Science

The company’s founder and chief executive officer, Ravi Srinivasan, took time to speak with BioSpace to discuss the company and its technology platform.

March 9, 2020
·
4 min read
·
Mark Terry
Drug Development

Bristol Myers Squibb’s Empliciti Flunks Late-Stage Multiple Myeloma Trial

The trial was assessing if multiple myeloma drug Empliciti could move forward as a front-line treatment for the disease.

March 9, 2020
·
2 min read
·
Alex Keown
Lonza Collaborates with Immunotherapy Leaders to Assess Point-of-Care Manufacturing for Cancer Cell Therapies

“We are extremely motivated to be working hand-in-hand with these premier institutes, among the leaders in cell-based immunotherapy discovery and development, to exhibit the use of the closed, automated Cocoon® Platform for manufacturing cell therapies.

March 9, 2020
·
4 min read
Marinomed Extends The Range of Marinosolv® Applications

Marinomed Biotech AG, a globally active biopharmaceutical company based in Vienna, has achieved promising results for further areas of application with its Marinosolv® technology platform in preclinical studies.

March 9, 2020
·
3 min read
Pharmaceutical Packaging Companies Focus on Durable and Eco-friendly Glass Ampoules

Pharmaceutical packaging processes have witnessed innovations in the past decade.

March 9, 2020
·
3 min read
FDA

Recordati and Novartis’ Isturisa Approved for Cushing’s Disease

Novartis’ Isturisa (osilodrostat) was approved for adults with Cushing’s disease who either can’t have pituitary gland surgery or who have had the surgery but still have the disease.

March 9, 2020
·
3 min read
·
Mark Terry
Experimental Fibrosis Drug May Help Immuno-Oncology Therapies

The research was published in the journal Cancer Research.

March 9, 2020
·
3 min read
·
Mark Terry
Deals

M&A Boosts the Landscape of Efficiency in the Pharma Industry

Mergers and acquisitions in the pharmaceutical industry are not only a positive for the company that has made a bid for another company, but it is also good for the industry as a whole because of increases in efficiency across the entire field.

March 9, 2020
·
3 min read
·
Alex Keown
Bio NC

10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says

GlobalData, a leading data and analytics company, pegged the 10 drugs to hit sales of $1 billion and more per year.

March 9, 2020
·
4 min read
·
Alex Keown